Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

GSK2556286 is a novel antitubercular drug candidate effective in vivo with the potential to shorten tuberculosis treatment

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.04.479214Source: DataRank Database

GSK2556286 is a novel antitubercular drug candidate effective in vivo with the potential to shorten tuberculosis treatment is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (18)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (30)

Maria Santos Martínez ORCID,Olalla Sanz ORCID,Beatriz Urones,Jorge Esquivias ORCID,Heena Soni ORCID

Live enrichment

PubMed:19910364 OpenAlex:https://openalex.org/W4210446795

Wellcome Trust

Grant: unidentified

unidentified

European Commission

Grant: 261378

Open Collaborative Model for Tuberculosis Lead Optimisation

greenLicense: cc-by-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2022/02/06/2022.02.04.479214.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.02.04.479214

repositoryhttps://doi.org/10.1101/2022.02.04.479214

Fields of Study

Tuberculosis Research and EpidemiologyDrug Transport and Resistance MechanismsCancer therapeutics and mechanisms0303 health sciences03 medical and health sciences

Keywords

TuberculosisMycobacterium tuberculosisDrugIn vivoPharmacologyMedicineDrug resistanceMultiple drug resistanceMode of actionBiologyMicrobiologyPathologyBiotechnology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being